carcinoembryonic antigen-expressing measles virus

BIOLOGICAL2 trials

Sponsors

Mayo Clinic

Conditions

Anaplastic AstrocytomaAnaplastic OligodendrogliomaMixed GliomaOvarian CancerPrimary Peritoneal Cavity CancerRecurrent Glioblastoma

Phase 1

Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

CompletedNCT00390299

Mayo ClinicAnaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma +1

Start: 2006-10-23End: 2019-11-30Updated: 2020-01-02

Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer

CompletedNCT00408590

Mayo ClinicOvarian Cancer, Primary Peritoneal Cavity Cancer

Start: 2004-04-19End: 2017-11-07Updated: 2024-01-16

Related Papers

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.

2024-01-1245 citations

Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients.

2023-08-1214 citations

Overcoming oncolysis resistance by double infections with vaccine-derived state-of-the-art virotherapeutics

Zeitschrift für Gastroenterologie2013-08-16